HUMAW
Humacyte, Inc. Warrant
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Humacyte, Inc. Warrant (HUMAW) Stock: Buy, Sell, or Hold?
$0.00
0.00 (-78.05%)
▼
5d:
-83.34%
30d:
-91.0%
90d:
-98.57%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (32%)
Quality Score
42/100
Position
FAIR
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.00 / $0.01
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: HUMAW is down 83.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When HUMAW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: HUMAW is currently trading at $0.00, which is considered fair based on recent price action.
Technical Outlook: Technically, HUMAW is in a strong downtrend. The price is currently testing key support at $0.00. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 78.0% recently.
Market Sentiment: HUMAW scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HUMAW is in a strong downtrend. The price is currently testing key support at $0.00. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 78.0% recently.
Market Sentiment: HUMAW scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
32.4%
Trading Range & Key Levels
Support Level
$0.00
Resistance Level
$0.01
Current Trend
Strong Downtrend
Technical data as of
Aug 25, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BEARISH: Downward momentum (-78.0%)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Share HUMAW Analysis
Share this live HUMAW analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 9:07 PM ET
Data refreshes hourly during market hours. Next update: 10:07 PM
Data refreshes hourly during market hours. Next update: 10:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HUMAW showing a specific setup today?
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive HUMAW Research Pages
